Angioedema, use of ACE inhibitors, and SARS-CoV-2 infection
DOI:
https://doi.org/10.32818/reccmi.a6n1a4Keywords:
angioedema, ACE inhibitors, bradykinin, SARS-CoV-2 infection.Abstract
The SARS-CoV-2 infection, as well as other viral infections, can lead to a considerable variety of cutaneous manifestations. However, angioedema is not usual, generally showing up associated with urticaria and respiratory symptoms. Its emergence in patients who are under ACE inhibitors is not common. It seems that the mechanism by which the virus and ACE inhibitors produce angioedema is similar, both causing dysregulation of ACE-2 receptors and increasing bradykinin levels. It is reasonable to believe that SARS-CoV-2 may act as a potential trigger when combined with the use of these products.
Downloads
Metrics
References
Galván Casas C, Català A, Carretero Hernández G, Rodríguez-Jiménez P, Fernández-Nieto D, Rodríguez-Villa Lario A, Navarro Fernández I et al. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases. Br J Dermatol. 2020; 183(1): 71-77. doi: ttps://doi.org/10.1111/bjd.19163.
Hassan K. Urticaria and angioedema as a prodromal cutaneous manifestation of SARS-CoV-2 (COVID-19) infection. BMJ Case Rep. 2020; 13(7): e236981. doi: https://doi.org/10.1136/bcr-2020-236981.
Abasaeed Elhag SA, Ibrahim H, Abdelhadi S. Angioedema and urticaria in a COVID-19 patient: A case report and review of the literature. JAAD Case Rep. 2020; 6(10): 1091-1094. doi: https://doi.org/10.1016/j.jdcr.2020.07.042.
Adeliño R, Andrés-Cordón JF, Aracelis De La Cruz Martínez C. Acute urticaria with angioedema in the setting of coronavirus disease 2019. J Allergy Clin Immunol Pract. 2020; 8(7): 2386-2387. doi: https://doi.org/10.1016/j.jaip.2020.04.061.
Grewal E, Sutarjono B, Mohammed I. Angioedema, ACE inhibitor and COVID-19. BMJ Case Rep. 2020 Sep 9;13(9):e237888. doi: https://doi.org/10.1136/bcr-2020-237888.
Cohen AJ, DiFrancesco MF, Solomon SD, Vaduganathan M. Angioedema in COVID-19. Eur Heart J. 2020; 41(34): 3283-3284. doi: https://doi.org/10.1093/eurheartj/ehaa452.
Xu H, Zhong L, Deng J, Peng J, Dan H, Zeng X et al. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int J Oral Sci. 2020; 12(1): 8. doi: https://doi.org/10.1038/s41368-020-0074-x.
Makani H, Messerli FH, Romero J, Wever-Pinzon O, Korniyenko A, Berrios RS et al. Meta-analysis of randomized trials of angioedema as an adverse event of renin-angiotensin system inhibitors. Am J Cardiol. 2012; 110(3): 383-91. doi: https://doi.org/10.1016/j.amjcard.2012.03.034.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Tamara Gómez-Traveso, Raquel Jaso-Tejera, Ana González-Torre-González, Elena Casuso-Sáenz, Nuria Díez-Herrán
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Permite compartir, copiar y redistribuir el material en cualquier medio o formato, bajo los siguientes términos:
Reconocimiento: debe otorgar el crédito correspondiente, proporcionar un enlace a la licencia e indicar si se realizaron cambios. Puede hacerlo de cualquier manera razonable, pero no de ninguna manera que sugiera que el licenciante lo respalda a usted o su uso.
No comercial: no puede utilizar el material con fines comerciales.
No Derivados: si remezcla, transforma o construye sobre el material, no puede distribuir el material modificado.
Sin restricciones adicionales: no puede aplicar términos legales o medidas tecnológicas que restrinjan legalmente a otros de hacer cualquier cosa que permita la licencia.
